Gadolinium-based contrast agent-free (GBCA-free) versus gadolinium-based contrast agent-enhanced (GBCA-enhanced) magnetic resonance imaging as a screening tool for intracranial tumors
BackgroundGBCA-enhanced MRI is considered the gold standard for diagnosing intracranial tumors. However, concerns regarding gadolinium-based contrast agents (GBCAs) and workflow limitations have led to increasing interest in GBCA-free MRI techniques.ObjectiveTo compare the diagnostic performance of...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2026-04-01
|
| Sarja: | Frontiers in Neuroimaging |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fnimg.2026.1776934/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
